/DSRLF
DSRLF Stock - DiaSorin S.p.A.
Healthcare|Medical - Diagnostics & ResearchOTC
$74.34+0.00%
+$0.00 (+0.00%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.11
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $81.77
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DSRLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$73.60 – $75.08
TARGET (TP)$85.49
STOP LOSS$68.39
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.53
52W High$112.30
52W Low$66.50
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.19B | $1.15B | $1.36B | $1.24B | $881.30M |
| Gross Profit | $781.70M | $741.19M | $900.61M | $824.77M | $602.90M |
| Gross Margin | 65.9% | 64.6% | 66.2% | 66.6% | 68.4% |
| Operating Income | $258.32M | $216.26M | $351.26M | $419.50M | $324.23M |
| Net Income | $188.10M | $159.85M | $240.91M | $310.97M | $247.87M |
| Net Margin | 15.9% | 13.9% | 17.7% | 25.1% | 28.1% |
| EPS | $3.37 | $2.87 | $4.17 | $5.44 | $4.53 |
Company Overview
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
0%
Hold / Neutral
3
75%
Sell / Underperform
1
25%
Analyst Consensus🔴 Bearish
0 Bullish4 Neutral/Bearish
Price Targets
No price targets available
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 9th 2024 | Barclays | Initiation | Equal Weight | - |
| April 3rd 2023 | Kepler | Downgrade | Reduce | - |
| March 9th 2023 | Exane BNP Paribas | Downgrade | Underperform | - |
| November 29th 2022 | Stifel | Initiation | Hold | - |
| October 18th 2022 | Morgan Stanley | Initiation | Equal Weight | - |
Earnings History & Surprises
DSRLFBeat Rate
50%
Last 6 quarters
Avg Surprise
+2.2%
EPS vs Estimate
Beats / Misses
3/3
Last 12 quarters
Latest EPS
$1.03
Q3 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q4 24
No data
Q1 25
-52.0%
$1.06vs$2.21
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Mar 2, 2026 | — | — | — | — |
Q4 2025 | Nov 5, 2025 | — | — | — | — |
Q3 2025 | Jul 31, 2025 | — | $1.03 | — | — |
Q1 2025 | Mar 13, 2025 | $2.21 | $1.06 | -52.0% | ✗ MISS |
Q4 2024 | Dec 31, 2024 | — | $0.91 | — | — |
Q4 2024 | Nov 5, 2024 | — | $0.93 | — | — |
Q3 2024 | Jul 29, 2024 | — | $1.01 | — | — |
Q2 2024 | May 10, 2024 | — | $0.93 | — | — |
Q4 2023 | Dec 30, 2023 | — | $0.99 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.49 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.92 | — | — |
Q1 2023 | Mar 27, 2023 | — | $0.85 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.65 | — | — |
Q4 2022 | Oct 27, 2022 | $0.90 | $1.14 | +26.7% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $1.10 | $1.04 | -5.5% | ✗ MISS |
Q2 2022 | May 6, 2022 | $1.14 | $1.47 | +28.9% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | — | $1.61 | — | — |
Q4 2021 | Nov 11, 2021 | $1.22 | $1.68 | +37.7% | ✓ BEAT |
Q3 2021 | Jul 30, 2021 | $1.69 | $1.31 | -22.5% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about DSRLF
What is DSRLF's current stock price?
DiaSorin S.p.A. (DSRLF) is currently trading at $74.34 per share. The stock has moved +0.00% today.
What is the analyst price target for DSRLF?
No analyst price targets are currently available for this stock.
What sector is DiaSorin S.p.A. in?
DiaSorin S.p.A. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is DSRLF's market cap?
DiaSorin S.p.A. has a market capitalization of $4.01 billion, making it a mid-cap company.
Does DSRLF pay dividends?
No, DiaSorin S.p.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCNVVF
ConvaTec Group Plc
$3.06
Mkt Cap: $6.3B
CNVVY
ConvaTec Group Plc
$12.86
Mkt Cap: $6.6B
FLMNF
Fielmann AG
$60.22
Mkt Cap: $5.1B
GNGBY
Getinge AB (publ)
$22.99
Mkt Cap: $6.3B
GZPHF
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
$2.14
Mkt Cap: $5.4B
OPHLF
Ono Pharmaceutical Co., Ltd.
$13.28
Mkt Cap: $6.2B
OPHLY
Ono Pharmaceutical Co., Ltd.
$4.56
Mkt Cap: $6.4B
RADLY
Raia Drogasil S.A.
$4.13
Mkt Cap: $6.8B
SKHCF
Sonic Healthcare Limited
$13.92
Mkt Cap: $6.9B
SKHHY
Sonic Healthcare Limited
$15.08
Mkt Cap: $7.2B
Explore stocks similar to DSRLF for comparison